NEW YORK, April 7, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

World In Vitro Diagnostics Market

Global demand to increase 6.1% annually through 2014

The Freedonia Group projects world demand for in vitro diagnostic (IVD) products increasing 6.1 percent annually to nearly $68 billion in 2014. Based on the advanced nature of medical delivery systems and widespread insurance coverage for primary health care procedures, the developed countries combined will absorb more than two-thirds of this total. Demand in the developing countries as a whole will expand faster as medical delivery systems are expanded and upgraded and the availability and accessibility of basic health care services improve.

Nucleic acid testing to be fastest growing type

Clinical chemistry and immunoassay will remain the top two IVD methodologies, the former based on sales of personal blood glucose monitors and test strips and the latter due to the penetration of high value-added chemiluminescent products into infectious disease and drug testing markets. Nucleic acid testing products will post the fastest growth in global demand gains among all IVD products based on throughput, accuracy and speed advantages, especially in the detection of infectious diseases and cancer markers. Because of increasing blood glucose monitoring among diabetic patients, endocrine condition testing will remain the largest IVD application through 2014 and beyond. Due to their ability to quantify heart attack and embolism risk prior to occurrence, hemostasis tests for D-dim